Ulta Beauty
ULTA
$475.36
-0.54%
Ulta Beauty is the largest specialized beauty retailer in the US, operating over 1,500 freestanding stores offering cosmetics, fragrances, skin care, hair care, and salon services. As the dominant player in the US beauty specialty retail space, it differentiates through a one-stop-shop model combining mass and prestige brands with in-store salon services. The current investor narrative centers on Ulta's ability to sustain growth amid a challenging macroeconomic environment, with recent Q1 FY2026 earnings beating expectations and an upward revision to full-year profit forecasts, though concerns about margin pressure and consumer spending persist.…
ULTA
Ulta Beauty
$475.36
Related headlines
Investment Opinion: Should I buy ULTA Today?
Rating: Buy. Ulta Beauty is a high-quality specialty retailer trading at a compelling forward P/E of 14.9x, with strong fundamentals and a consensus analyst target implying 31.2% upside. The core thesis is that the market is overly pessimistic about near-term headwinds, and the company's dominant market position, robust cash flow, and aggressive buybacks will drive shareholder value.
Supporting evidence: (1) Forward P/E of 14.9x is a 17% discount to the industry average of 18x and near the low end of its 5-year range. (2) Revenue grew 11.1% YoY in Q1, outpacing many retail peers. (3) Net margin of 10.8% and ROE of 41.1% demonstrate superior profitability. (4) Free cash flow of $1.048 billion supports a $557 million buyback in Q1 alone. (5) Analyst average target of $623.42 implies 31.2% upside, with a high target of $735 (54.6% upside).
Risks & Conditions: The biggest risks are decelerating revenue growth (from 14.7% to 11.1%) and margin pressure (operating margin flat at 14.2%). This Buy rating would be downgraded to Hold if revenue growth falls below 8% or if gross margin contracts below 39%. It would be upgraded to Strong Buy if the forward P/E compresses below 12x or if the company announces a dividend initiation. Overall, ULTA appears undervalued relative to its forward earnings power and historical valuation, offering a favorable risk/reward for patient investors.
Sign up to view all
ULTA 12-Month Price Forecast
Ulta Beauty presents a compelling risk/reward at current levels. The forward P/E of 14.9x is cheap relative to the industry and the company's own history, and the strong Q1 beat with raised guidance suggests the business is fundamentally sound. However, the stock's persistent underperformance and decelerating growth warrant caution. The base case of a recovery toward $600 (26% upside) is most likely, supported by analyst targets and earnings momentum. The bull case of $735 (55% upside) requires sustained growth and margin expansion, while the bear case of $450 (5% downside) is limited by the 52-week low. We would upgrade to higher confidence if the next quarter shows accelerating revenue growth or if the stock breaks above its 50-day moving average.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ulta Beauty's 12-month outlook, with a consensus price target around $623.42 and implied upside of +31.1% versus the current price.
Average Target
$623.42
0 analysts
Implied Upside
+31.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$450 - $735
Analyst target range
ULTA is covered by 24 analysts, with a consensus recommendation of 'Buy' (mean rating 1.81 on a 1-5 scale where 1 is Strong Buy). The average price target is $623.42, implying 31.2% upside from the current price of $475.36. The distribution leans bullish: 10 recent ratings include 7 Buy/Overweight, 2 Neutral, and 1 Underweight, indicating broad optimism despite the stock's recent decline. The target range spans from a low of $450 to a high of $735. The high target of $735 assumes a return to historical valuation multiples and sustained growth, while the low target of $450 suggests downside risk if margin pressure or competitive threats intensify. The wide spread ($285) reflects high uncertainty about the company's near-term trajectory. Recent analyst actions show no downgrades; firms like TD Cowen, Goldman Sachs, and UBS reiterated Buy ratings after Q1 results, signaling confidence in the turnaround. The strong consensus and significant upside potential suggest the market may be overly pessimistic, but the wide range indicates that risks remain elevated.
Drowning in data?
Find the real signal!
Bulls vs Bears: ULTA Investment Factors
Ulta Beauty presents a compelling value opportunity with a forward P/E of 14.9x, strong profitability (10.8% net margin, 41.1% ROE), and analyst consensus Buy with 31.2% upside. However, the stock faces headwinds from decelerating revenue growth (11.1% YoY, down from 14.7%), a high trailing P/E of 25.2x, and significant relative weakness (-7.4% 1-year vs S&P +16.5%). The bull case is supported by the Q1 beat, raised guidance, and aggressive buybacks, while the bear case centers on margin pressure and macro risks. The single most important tension is whether Ulta can sustain double-digit revenue growth and margin expansion to justify the forward multiple; if growth decelerates further, the stock could re-rate lower, but if earnings materialize as expected, the current price offers a significant margin of safety.
Bullish
- Strong Q1 Beat and Raised Guidance: Ulta reported Q1 FY2026 revenue of $3.164 billion, up 11.1% YoY, beating expectations and raising full-year profit forecasts. This demonstrates resilient consumer demand and effective execution despite macro headwinds.
- Compelling Forward Valuation: The forward P/E of 14.9x is at a 17% discount to the specialty retail industry average of 18x, and near the low end of its 5-year historical range (12x-25x). If earnings materialize as expected ($43.65 EPS), the stock appears undervalued.
- Robust Profitability and Cash Flow: Trailing twelve-month net income is $1.19 billion with a net margin of 10.8%, and free cash flow of $1.048 billion supports aggressive share buybacks ($557 million in Q1 alone). ROE is an impressive 41.1%, reflecting efficient capital use.
- Analyst Consensus Strong Buy: 24 analysts rate ULTA a Buy (mean 1.81 on 1-5 scale) with an average price target of $623.42, implying 31.2% upside. No recent downgrades, and firms like TD Cowen and Goldman Sachs reiterated Buy after Q1 results.
Bearish
- Decelerating Revenue Growth: Revenue growth slowed from 14.7% in Q4 FY2025 to 11.1% in Q1 FY2026, and the prior-year quarter also grew 11.2%. This deceleration suggests normalization after pandemic surges and potential demand softening.
- High Trailing P/E Premium: The trailing P/E of 25.2x is a 40% premium to the industry average of 18x and near the top of its 5-year range. This implies optimistic expectations are already priced in, leaving little room for error.
- Significant Relative Weakness: ULTA has declined 7.4% over the past year versus the S&P 500's +16.5%, and is down 30.7% over six months. The stock trades at only 33% of its 52-week range, indicating persistent bearish sentiment and potential further downside.
- Margin Pressure Concerns: Despite Q1 gross margin expansion, operating margin was flat at 14.2% YoY, and the Q4 FY2025 earnings beat was overshadowed by rising costs. The 3-month decline of 14.9% accelerated after Q4 results, reflecting investor anxiety about cost control.
ULTA Technical Analysis
ULTA is in a sustained downtrend, with the stock declining 7.4% over the past year and currently trading at 475.36, which is only 33% of its 52-week range (52-week low: 443.60, high: 714.97). The price sits near the lower end of the range, suggesting bearish sentiment and potential value opportunity, but also risk of further downside if support fails. The 1-year price change of -7.4% contrasts sharply with the S&P 500's +16.5% gain, indicating significant relative weakness. Short-term momentum remains negative: the 1-month change is -0.7% and the 3-month change is -14.9%, both underperforming the S&P 500's +0.8% and +3.5% respectively. The 3-month decline of -14.9% is steeper than the 1-year decline, signaling accelerating bearish momentum and potential capitulation. The RSI is not provided, but the persistent decline suggests oversold conditions may be emerging. The 52-week low of 443.60 provides key support; a breakdown below this level could trigger further selling toward the 400 area. Resistance sits at the 52-week high of 714.97, a 50%+ rally from current levels. With a beta of 0.88, ULTA is less volatile than the market, meaning it may not rebound as sharply in a rally but also offers relative downside protection during market declines.
Beta
0.88
0.88x market volatility
Max Drawdown
-36.2%
Largest decline past year
52-Week Range
$444-$715
Price range past year
Annual Return
-7.4%
Cumulative gain past year
| Period | ULTA Return | S&P 500 |
|---|---|---|
| 1m | -0.7% | +1.4% |
| 3m | -14.9% | +3.3% |
| 6m | -30.7% | +6.3% |
| 1y | -7.4% | +16.0% |
| ytd | -23.3% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ULTA Fundamental Analysis
Revenue growth is solid but decelerating: Q1 FY2026 (May 2, 2026) revenue was $3.164 billion, up 11.1% year-over-year, but this compares to 11.2% growth in the prior-year quarter and a multi-quarter trend of slowing from 14.7% in Q4 FY2025. The retail stores segment generated $1.737 billion, e-commerce $294 million, and salon $77 million, with all segments contributing positively. The 11.1% growth is still healthy, but the deceleration suggests normalization after pandemic-era surges. Profitability remains robust: net income for Q1 was $340.5 million, with a net margin of 10.8%, while gross margin expanded to 40.1% from 39.1% a year ago. Operating margin was 14.2%, down slightly from 14.2% in the prior-year quarter, indicating stable cost control. The company is consistently profitable with a trailing twelve-month net income of $1.19 billion. The balance sheet is healthy: debt-to-equity is 0.78, and the current ratio is 1.41, indicating adequate liquidity. Free cash flow for the trailing twelve months was $1.048 billion, providing ample capacity for share buybacks (the company repurchased $557 million in stock in Q1 alone) and organic investments. ROE is strong at 41.1%, reflecting efficient capital use.
Quarterly Revenue
$3.2B
2026-05
Revenue YoY Growth
+11.1%
YoY Comparison
Gross Margin
40.1%
Latest Quarter
Free Cash Flow
$1.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ULTA Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 25.2x, while the forward P/E is 14.9x, implying the market expects significant earnings growth in the coming year. The gap between trailing and forward P/E suggests the market is pricing in a sharp earnings recovery, which aligns with analyst estimates of $43.65 EPS for the current fiscal year. Compared to the specialty retail industry average P/E of approximately 18x (based on sector data), ULTA's trailing P/E of 25.2x represents a 40% premium, but the forward P/E of 14.9x is at a 17% discount, indicating that current earnings are depressed relative to future expectations. Historically, ULTA's trailing P/E has ranged from 12x to 25x over the past five years; the current 25.2x is near the top of that range, suggesting the market is pricing in optimistic growth expectations. However, the forward P/E of 14.9x is near the lower end of the historical range, implying that if earnings materialize as expected, the stock could be undervalued. The P/S ratio of 2.34x is below the 5-year average of 3.5x, further supporting a value argument.
PE
25.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 12x~23x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Ulta's debt-to-equity of 0.78 is manageable, but the company carries $652,000 in interest expense in Q1. The trailing P/E of 25.2x is elevated relative to the industry average of 18x, implying high earnings expectations. If revenue growth decelerates below 10% or margins contract, the stock could face multiple compression. The 11.1% YoY revenue growth in Q1 is decelerating from 14.7% in Q4, signaling potential normalization. Free cash flow of $1.048 billion is strong, but the aggressive buyback program ($557 million in Q1) reduces equity cushion and increases financial leverage.
Market & Competitive Risks: ULTA's beta of 0.88 indicates lower market correlation, but the stock has underperformed the S&P 500 by 23.9 percentage points over the past year. The 52-week low of $443.60 is only 6.7% below the current price, suggesting limited downside support. Competitive threats from Sephora (expanding at Kohl's) and online retailers like Amazon could pressure market share. The recent Q4 earnings beat was overshadowed by margin concerns, causing a sharp 14.9% 3-month decline. Stagflation fears from sticky inflation and slowing GDP could further dampen consumer spending on discretionary beauty products.
Worst-Case Scenario: A severe recession combined with intensified competition could cause Ulta to miss earnings estimates, leading to analyst downgrades and multiple compression. If the stock revisits its 52-week low of $443.60, that represents a 6.7% downside from the current price of $475.36. However, if macro conditions deteriorate further, the stock could fall to the analyst low target of $450 (5.3% downside) or even lower to $400, implying a 15.9% loss. The historical max drawdown of -36.23% suggests that in a worst-case scenario, an investor could lose up to 36% from peak, but from current levels, a drop to $400 would be a 15.9% decline.
FAQ
The key risks are: (1) Decelerating revenue growth – Q1 growth of 11.1% is down from 14.7% in Q4, and further deceleration could lead to multiple compression. (2) Margin pressure – operating margin was flat at 14.2% YoY, and rising costs could squeeze profitability. (3) Macroeconomic headwinds – sticky inflation and slowing GDP could reduce consumer spending on beauty products, impacting sales. (4) Competitive threats – Sephora's expansion at Kohl's and online retailers like Amazon could erode market share. The most severe risk is a recession that causes a sharp earnings miss, potentially driving the stock to the analyst low target of $450 (5.3% downside) or lower. However, the company's strong balance sheet and cash flow provide a buffer.
The 12-month forecast is positive, with a base case target of $500-$600 (5-26% upside) based on a forward P/E of 15-17x and analyst estimates of $43.65 EPS. The bull case sees the stock reaching $600-$735 (26-55% upside) if growth accelerates and margins expand, while the bear case could see it fall to $400-$500 (16-5% downside) in a recession. The most likely scenario (50% probability) is a recovery toward the analyst average target of $623.42, implying 31.2% upside. Key assumptions include sustained revenue growth of 8-10% and stable margins. The stock's current price of $475.36 is near the low end of its 52-week range, suggesting limited downside and significant upside potential if the company executes.
ULTA appears undervalued on a forward basis but overvalued on a trailing basis. The trailing P/E of 25.2x is a 40% premium to the industry average of 18x, suggesting the market is pricing in high growth expectations. However, the forward P/E of 14.9x is a 17% discount to the industry and near the low end of its 5-year historical range of 12x-25x. This implies that if the company achieves the estimated EPS of $43.65, the stock is cheap. The P/S ratio of 2.34x is also below the 5-year average of 3.5x, further supporting the undervaluation thesis. The market appears to be discounting near-term macro risks, creating a potential opportunity for investors who believe in the company's long-term growth story.
Yes, ULTA appears to be a good buy for investors with a 12-month horizon. The stock trades at a forward P/E of 14.9x, a 17% discount to the specialty retail industry average of 18x, and analysts see 31.2% upside to the average target of $623.42. The company reported a strong Q1 beat with 11.1% revenue growth and raised full-year guidance, supported by robust free cash flow of $1.048 billion and aggressive buybacks ($557 million in Q1). The biggest downside risk is a recession that further decelerates growth, but the 52-week low of $443.60 provides a floor only 6.7% below the current price. For long-term investors, the forward valuation offers a margin of safety, making it a compelling entry point.
ULTA is better suited for long-term investment (12+ months) due to its strong fundamentals, dominant market position, and attractive forward valuation. The stock has a beta of 0.88, meaning it is less volatile than the market, but it has been in a sustained downtrend, declining 30.7% over six months. Short-term traders may find the stock risky due to negative momentum and potential further declines to the 52-week low of $443.60. However, for long-term investors, the forward P/E of 14.9x and analyst consensus Buy provide a compelling entry point. The company does not pay a dividend, so returns will come from price appreciation. A minimum holding period of 12 months is recommended to allow the earnings story to play out and for the stock to re-rate higher.
